机构:[1]Capital Med Univ, Natl Clin Res Ctr Geriatr Disorders, Dept Geriatr, Xuanwu Hosp, Beijing, Peoples R China首都医科大学宣武医院[2]Cent South Univ, Dept Geriatr, Xiangya Hosp, Changsha, Peoples R China[3]Cent South Univ, Xiangya Hosp, Natl Clin Res Ctr Geriatr Disorders, Changsha, Peoples R China[4]Zhejiang Hosp, Dept Geriatr, Hangzhou, Peoples R China[5]Sichuan Univ, Dept Geriatr, West China Hosp, Chengdu, Peoples R China四川大学华西医院[6]Fujian Med Univ Union Hosp, Dept Geriatr, Fuzhou, Peoples R China
BackgroundMobility limitation-the loss of exercise capacity or independent living ability-is a common geriatric syndrome in older adults. As a potentially reversible precursor to disability, mobility limitation is influenced by various factors. Moreover, its complex physiological mechanism hinders good therapeutic outcomes with a single-factor intervention. Most hospitals have not incorporated the diagnosis and evaluation of mobility limitation into medical routines nor developed a multidisciplinary team (MDT) treatment plan. We aim to conduct a clinical trial titled "A Multidisciplinary-team approach for management of Mobility Limitation in Elderly (M-MobiLE)" to explore the effect of the MDT decision-making intervention for mobility limitation.MethodsThe M-MobiLE study will be a multicenter, randomized, and controlled trial. We will recruit a minimum of 66 older inpatients with mobility limitation from at least five hospitals. Older patients with mobility limitation admitted to the geriatrics department will be included. Short-Physical Performance Battery (SPPB), Activities of Daily Living (ADL), Function Impairment Screening Tool (FIST), Geriatric Depression Scale (GDS-15), Short Form - 12 (SF-12), Fried frailty phenotype, social frailty, Morse Fall Risk Scale, SARC-CalF, Mini-Mental State Examination (MMSE), Mini-Nutritional Assessment Short-Form (MNA-SF), and intrinsic capacity will be assessed. The intervention group will receive an exercise-centered individualized MDT treatment, including exercise, educational, nutritional, medical, and comorbidity interventions; the control group will receive standard medical treatment. The primary outcome is the change in the SPPB score, and the secondary outcomes include increased SF-12, ADL, FIST, MMSE, MNA-SF, and intrinsic capacity scores and decreased GDS-15 and SARC-CalF scores.ConclusionOur results will help develop a multidisciplinary decision-making clinical pathway for inpatients with mobility limitation, which can be used to identify patients with mobility limitation more effectively, improve mobility, and reduce the risk of falls, frailty, and death in older inpatients. The implementation of this MDT strategy may standardize the treatment of mobility limitation, reduce adverse prognosis, and improve quality of life.
基金:
This work was supported by the National Key R&D Program of China
(2020YFC2008604 and 2020YFC2008600).
第一作者机构:[1]Capital Med Univ, Natl Clin Res Ctr Geriatr Disorders, Dept Geriatr, Xuanwu Hosp, Beijing, Peoples R China
通讯作者:
推荐引用方式(GB/T 7714):
Wang Guanzhen,Zhang Li,Ji Tong,et al.A protocol for randomized controlled trial on multidisciplinary interventions for mobility limitation in the older adults (M-MobiLE)[J].BMC GERIATRICS.2023,23(1):doi:10.1186/s12877-023-04117-4.
APA:
Wang, Guanzhen,Zhang, Li,Ji, Tong,Zhang, Wanshu,Peng, Linlin...&Ma, Lina.(2023).A protocol for randomized controlled trial on multidisciplinary interventions for mobility limitation in the older adults (M-MobiLE).BMC GERIATRICS,23,(1)
MLA:
Wang, Guanzhen,et al."A protocol for randomized controlled trial on multidisciplinary interventions for mobility limitation in the older adults (M-MobiLE)".BMC GERIATRICS 23..1(2023)